Global Pharmaceutical Intermediates Market Insights, Forecast to 2026

Global Pharmaceutical Intermediates Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market Segments
1.3 Key Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
1.4.2 GMP
1.4.3 Non-GMP
1.5 Market by Application
1.5.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application
1.5.2 Antibiotics
1.5.3 Antipyretic Analgesics
1.5.4 Vitamins
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Intermediates Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical Intermediates Industry
1.6.1.1 Pharmaceutical Intermediates Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical Intermediates Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
2.1.1 Global Pharmaceutical Intermediates Revenue 2015-2026
2.1.2 Global Pharmaceutical Intermediates Sales 2015-2026
2.2 Pharmaceutical Intermediates Market Size by Region: 2020 Versus 2026
2.2.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pharmaceutical Intermediates Competitor Landscape by Players
3.1 Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Pharmaceutical Intermediates Sales by Manufacturers (2015-2020)
3.1.2 Pharmaceutical Intermediates Sales Market Share by Manufacturers (2015-2020)
3.2 Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020)
3.2.2 Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2019
3.2.5 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pharmaceutical Intermediates Price by Manufacturers
3.4 Pharmaceutical Intermediates Manufacturing Base Distribution, Product Types
3.4.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharmaceutical Intermediates Product Type
3.4.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmaceutical Intermediates Market Size by Type (2015-2020)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2015-2020)
4.1.2 Global Pharmaceutical Intermediates Revenue by Type (2015-2020)
4.1.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pharmaceutical Intermediates Market Size Forecast by Type (2021-2026)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2021-2026)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2021-2026)
4.2.3 Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pharmaceutical Intermediates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Pharmaceutical Intermediates Market Size by Application (2015-2020)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2015-2020)
5.1.2 Global Pharmaceutical Intermediates Revenue by Application (2015-2020)
5.1.3 Pharmaceutical Intermediates Price by Application (2015-2020)
5.2 Pharmaceutical Intermediates Market Size Forecast by Application (2021-2026)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2021-2026)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pharmaceutical Intermediates by Country
6.1.1 North America Pharmaceutical Intermediates Sales by Country
6.1.2 North America Pharmaceutical Intermediates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pharmaceutical Intermediates Market Facts & Figures by Type
6.3 North America Pharmaceutical Intermediates Market Facts & Figures by Application
7 Europe
7.1 Europe Pharmaceutical Intermediates by Country
7.1.1 Europe Pharmaceutical Intermediates Sales by Country
7.1.2 Europe Pharmaceutical Intermediates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pharmaceutical Intermediates Market Facts & Figures by Type
7.3 Europe Pharmaceutical Intermediates Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pharmaceutical Intermediates by Region
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Type
8.3 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pharmaceutical Intermediates by Country
9.1.1 Latin America Pharmaceutical Intermediates Sales by Country
9.1.2 Latin America Pharmaceutical Intermediates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Type
9.3 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pharmaceutical Intermediates by Country
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Type
10.3 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Application
11 Company Profiles
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Description, Business Overview and Total Revenue
11.2.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Catalent Pharmaceutical Intermediates Products Offered
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Corporation Information
11.3.2 Patheon Description, Business Overview and Total Revenue
11.3.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Patheon Pharmaceutical Intermediates Products Offered
11.3.5 Patheon Recent Development
11.4 Jubilant
11.4.1 Jubilant Corporation Information
11.4.2 Jubilant Description, Business Overview and Total Revenue
11.4.3 Jubilant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Jubilant Pharmaceutical Intermediates Products Offered
11.4.5 Jubilant Recent Development
11.5 Granules
11.5.1 Granules Corporation Information
11.5.2 Granules Description, Business Overview and Total Revenue
11.5.3 Granules Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Granules Pharmaceutical Intermediates Products Offered
11.5.5 Granules Recent Development
11.6 Ganesh
11.6.1 Ganesh Corporation Information
11.6.2 Ganesh Description, Business Overview and Total Revenue
11.6.3 Ganesh Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ganesh Pharmaceutical Intermediates Products Offered
11.6.5 Ganesh Recent Development
11.7 Chemcon
11.7.1 Chemcon Corporation Information
11.7.2 Chemcon Description, Business Overview and Total Revenue
11.7.3 Chemcon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chemcon Pharmaceutical Intermediates Products Offered
11.7.5 Chemcon Recent Development
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Description, Business Overview and Total Revenue
11.8.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BASF Pharmaceutical Intermediates Products Offered
11.8.5 BASF Recent Development
11.9 Porton
11.9.1 Porton Corporation Information
11.9.2 Porton Description, Business Overview and Total Revenue
11.9.3 Porton Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Porton Pharmaceutical Intermediates Products Offered
11.9.5 Porton Recent Development
11.10 Lianhetech
11.10.1 Lianhetech Corporation Information
11.10.2 Lianhetech Description, Business Overview and Total Revenue
11.10.3 Lianhetech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
11.10.5 Lianhetech Recent Development
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.12 Tianma
11.12.1 Tianma Corporation Information
11.12.2 Tianma Description, Business Overview and Total Revenue
11.12.3 Tianma Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tianma Products Offered
11.12.5 Tianma Recent Development
11.13 Jiujiujiu
11.13.1 Jiujiujiu Corporation Information
11.13.2 Jiujiujiu Description, Business Overview and Total Revenue
11.13.3 Jiujiujiu Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Jiujiujiu Products Offered
11.13.5 Jiujiujiu Recent Development
11.14 Alpha
11.14.1 Alpha Corporation Information
11.14.2 Alpha Description, Business Overview and Total Revenue
11.14.3 Alpha Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alpha Products Offered
11.14.5 Alpha Recent Development
11.15 Jiuzhou
11.15.1 Jiuzhou Corporation Information
11.15.2 Jiuzhou Description, Business Overview and Total Revenue
11.15.3 Jiuzhou Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Jiuzhou Products Offered
11.15.5 Jiuzhou Recent Development
11.16 Yongtai
11.16.1 Yongtai Corporation Information
11.16.2 Yongtai Description, Business Overview and Total Revenue
11.16.3 Yongtai Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Yongtai Products Offered
11.16.5 Yongtai Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pharmaceutical Intermediates Market Estimates and Projections by Region
12.1.1 Global Pharmaceutical Intermediates Sales Forecast by Regions 2021-2026
12.1.2 Global Pharmaceutical Intermediates Revenue Forecast by Regions 2021-2026
12.2 North America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.2.1 North America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.2.2 North America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.2.3 North America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.3 Europe Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.3.1 Europe: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.3.2 Europe: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.3.3 Europe: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pharmaceutical Intermediates Market Size Forecast by Region (2021-2026)
12.5 Latin America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.5.1 Latin America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.5.2 Latin America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.5.3 Latin America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pharmaceutical Intermediates Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pharmaceutical Intermediates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Pharmaceutical Intermediates Market Segments
Table 2. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pharmaceutical Intermediates Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of GMP
Table 5. Major Manufacturers of Non-GMP
Table 6. COVID-19 Impact Global Market: (Four Pharmaceutical Intermediates Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pharmaceutical Intermediates Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
Table 11. Global Pharmaceutical Intermediates Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Pharmaceutical Intermediates Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pharmaceutical Intermediates Sales by Regions 2015-2020 (K MT)
Table 14. Global Pharmaceutical Intermediates Sales Market Share by Regions (2015-2020)
Table 15. Global Pharmaceutical Intermediates Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pharmaceutical Intermediates Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2015-2020)
Table 18. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2019)
Table 20. Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pharmaceutical Intermediates Price (2015-2020) (USD/MT)
Table 23. Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pharmaceutical Intermediates Product Type
Table 25. Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 28. Global Pharmaceutical Intermediates Sales Share by Type (2015-2020)
Table 29. Global Pharmaceutical Intermediates Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pharmaceutical Intermediates Revenue Share by Type (2015-2020)
Table 31. Pharmaceutical Intermediates Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 33. Global Pharmaceutical Intermediates Sales Share by Application (2015-2020)
Table 34. North America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 35. North America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 36. North America Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 38. North America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 39. North America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 40. North America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 41. North America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 42. Europe Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 43. Europe Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 44. Europe Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 46. Europe Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 47. Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 48. Europe Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 49. Europe Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pharmaceutical Intermediates Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 58. Latin America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 59. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 63. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 64. Latin America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 65. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 74. Lonza Corporation Information
Table 75. Lonza Description and Major Businesses
Table 76. Lonza Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Lonza Product
Table 78. Lonza Recent Development
Table 79. Catalent Corporation Information
Table 80. Catalent Description and Major Businesses
Table 81. Catalent Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Catalent Product
Table 83. Catalent Recent Development
Table 84. Patheon Corporation Information
Table 85. Patheon Description and Major Businesses
Table 86. Patheon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Patheon Product
Table 88. Patheon Recent Development
Table 89. Jubilant Corporation Information
Table 90. Jubilant Description and Major Businesses
Table 91. Jubilant Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Jubilant Product
Table 93. Jubilant Recent Development
Table 94. Granules Corporation Information
Table 95. Granules Description and Major Businesses
Table 96. Granules Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Granules Product
Table 98. Granules Recent Development
Table 99. Ganesh Corporation Information
Table 100. Ganesh Description and Major Businesses
Table 101. Ganesh Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Ganesh Product
Table 103. Ganesh Recent Development
Table 104. Chemcon Corporation Information
Table 105. Chemcon Description and Major Businesses
Table 106. Chemcon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Chemcon Product
Table 108. Chemcon Recent Development
Table 109. BASF Corporation Information
Table 110. BASF Description and Major Businesses
Table 111. BASF Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. BASF Product
Table 113. BASF Recent Development
Table 114. Porton Corporation Information
Table 115. Porton Description and Major Businesses
Table 116. Porton Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Porton Product
Table 118. Porton Recent Development
Table 119. Lianhetech Corporation Information
Table 120. Lianhetech Description and Major Businesses
Table 121. Lianhetech Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lianhetech Product
Table 123. Lianhetech Recent Development
Table 124. ABA Chem Corporation Information
Table 125. ABA Chem Description and Major Businesses
Table 126. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. ABA Chem Product
Table 128. ABA Chem Recent Development
Table 129. Tianma Corporation Information
Table 130. Tianma Description and Major Businesses
Table 131. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Tianma Product
Table 133. Tianma Recent Development
Table 134. Jiujiujiu Corporation Information
Table 135. Jiujiujiu Description and Major Businesses
Table 136. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Jiujiujiu Product
Table 138. Jiujiujiu Recent Development
Table 139. Alpha Corporation Information
Table 140. Alpha Description and Major Businesses
Table 141. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Alpha Product
Table 143. Alpha Recent Development
Table 144. Jiuzhou Corporation Information
Table 145. Jiuzhou Description and Major Businesses
Table 146. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Jiuzhou Product
Table 148. Jiuzhou Recent Development
Table 149. Yongtai Corporation Information
Table 150. Yongtai Description and Major Businesses
Table 151. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Yongtai Product
Table 153. Yongtai Recent Development
Table 154. Global Pharmaceutical Intermediates Sales Forecast by Regions (2021-2026) (K MT)
Table 155. Global Pharmaceutical Intermediates Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Pharmaceutical Intermediates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 159. North America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 161. Europe: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Pharmaceutical Intermediates Sales Forecast by Region (2021-2026) (K MT)
Table 163. Asia Pacific: Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 165. Latin America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 167. Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Pharmaceutical Intermediates Players
Table 172. Pharmaceutical Intermediates Customers List
Table 173. Pharmaceutical Intermediates Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2026
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2026
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Market Size 2015-2026 (US$ Million)
Figure 12. Global Pharmaceutical Intermediates Sales 2015-2026 (K MT)
Figure 13. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 16. Global Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 18. Global Pharmaceutical Intermediates Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediates Revenue in 2019
Figure 20. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Figure 22. Global Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 23. Global Pharmaceutical Intermediates Revenue Market Share by Type (2015-2020)
Figure 24. Global Pharmaceutical Intermediates Revenue Market Share by Type in 2019
Figure 25. Global Pharmaceutical Intermediates Market Share by Price Range (2015-2020)
Figure 26. Global Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Figure 27. Global Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 28. Global Pharmaceutical Intermediates Revenue Market Share by Application (2015-2020)
Figure 29. Global Pharmaceutical Intermediates Revenue Market Share by Application in 2019
Figure 30. North America Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 33. North America Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 34. U.S. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pharmaceutical Intermediates Market Share by Type in 2019
Figure 39. North America Pharmaceutical Intermediates Market Share by Application in 2019
Figure 40. Europe Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 43. Europe Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 44. Germany Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pharmaceutical Intermediates Market Share by Type in 2019
Figure 55. Europe Pharmaceutical Intermediates Market Share by Application in 2019
Figure 56. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 60. China Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pharmaceutic

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs